Table 1

Baseline characteristics of patients (n = 68)

Values are presented as mean (SD) unless otherwise indicated.
Demographics
    Age (years)52.9 (12)
    Female, No (%)51 (75)
    Disease duration (years)10.7 (8.7)
    Rheumatoid factor positive, No (%)49 (72)
    Number of previous DMARDs2.6
Concomitant treatment
    Concomitant methotrexate, No (%)55 (81)
    Methotrexate dose (mg/week)13.0 (3.5)
    Concomitant corticosteroids, No (%)41 (60)
    Corticosteroids dose (mg/day)9.1 (4.5)
Disease characteristics
    Ritchie index28.1 (14.3)
    Swollen joints (44)19.7 (11.3)
    DAS5.4 (1.5)
    ESR (mm/1st h)44.3 (25.6)
    CRP (mg/l)29 (36)
    Haemoglobin (g/l)120 (14)
    Patient’s global assessment (1–10)6.0 (2.3)
    Doctor’s global assessment (1–5)3.1 (0.8)
    HAQ (0–3)1.4 (0.6)
    VAS for pain6.4 (2.2)